Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

BioNexus Gene Lab (BGLC) Other Operating Expenses (2024 - 2025)

Historic Other Operating Expenses for BioNexus Gene Lab (BGLC) over the last 2 years, with Q3 2025 value amounting to $281696.0.

  • BioNexus Gene Lab's Other Operating Expenses fell 4728.91% to $281696.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.5 million, marking a year-over-year decrease of 83928.9%. This contributed to the annual value of -$8.9 million for FY2024, which is 447.79% up from last year.
  • BioNexus Gene Lab's Other Operating Expenses amounted to $281696.0 in Q3 2025, which was down 4728.91% from $142639.0 recorded in Q2 2025.
  • BioNexus Gene Lab's Other Operating Expenses' 5-year high stood at $534417.0 during Q3 2024, with a 5-year trough of -$9.1 million in Q4 2024.